Amgen's First Biosimilar Marketing Authorization Application Submitted To European Medicines Agency For ABP 501
Teva Announces Pricing of Public Offerings of American Depositary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Actavis Generics
EISAI TO ACQUIRE CHINESE GENERIC PHARMACEUTICAL COMPANY LIAONING TIANYI BIOLOGICAL PHARMACEUTICAL CO., LTD.
ABBVIE ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR A ONCE-DAILY FORMULATION OF VIEKIRA PAK® (OMBITASVIR, PARITAPREVIR, AND RITONAVIR TABLETS; DASABUVIR TABLETS) TO TREAT GENOTYPE 1 CHRONIC HEPATITIS C VIRUS INFECTION
GSK Announces Nucala® (mepolizumab), Now Available In The Us For Sub-Group Of Patients With Severe Asthma
Propeller Health Announces Development Agreement and R&D Collaboration with GSK to Develop a Digital Sensor for the Ellipta® Inhaler
Algorithme Pharma Announces the Appointment of an Executive Vice President, Phase I Clinical Development
Laval, Québec, Canada, November 30, 2015 – Algorithme Pharma of the Altasciences Group, a full service provider focused on early stage clinical research, today announced the addition of...